New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 31, 2013
07:41 EDTUTHRUnited Therapeutics price target raised to $130 from $120 at Argus
Argus increased its price target on United Therapeutics after the company announced that the FDA had approved its extended-release tablets for the treatment of pulmonary arterial hypertension. The firm believes that United Therapeutics is a mid-cap growth company that appears to be priced similar to more mature, slower-growth pharma companies. It keeps a Buy rating on the stock.
News For UTHR From The Last 14 Days
Check below for free stories on UTHR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2014
07:24 EDTUTHRInternational Society for Heart & Lung Transplantation to hold annual meeting
Subscribe for More Information
April 8, 2014
07:22 EDTUTHRCaSA-ISPE to hold a conference
21st Annual Lilfe Sciences Technology Conference is being held in Raleigh, North Carolina on April 8.
April 7, 2014
11:17 EDTUTHRUnited Therapeutics upgraded to Buy from Hold at Standpoint Research
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use